Verdict: J&J Must Pay $4M For Oral Cleft Birth Defects From Topamax
Posted by Marilyn McGoldrick on Nov 5, 2013 3:30:00 AM Johnson & Johnson’s Janssen Pharmaceutical unit has been ordered to pay $4.02 million in a lawsuit claiming its anti-seizure drug Topamax was responsible for a child’s birth defect, a Philadelphia jury said...
Johnson & Johnson Reportedly Settles Depuy ASR Hip Implant Lawsuit
Posted by Marilyn McGoldrick on Oct 16, 2013 4:30:00 PM A second DePuy ASR hip implant case scheduled for trial this month has been resolved, according to court records. The lawsuit, MacDonald et al v. DePuy Orthopaedics Inc. et al, was filed in the Bergen County...
DePuy ASR Settlement Reached In California: A Trend?
Posted by Marilyn McGoldrick on Oct 7, 2013 4:30:00 AM Johnson & Johnson subsidiary DePuy Orthopaedics has agreed to settle a DePuy ASR hip lawsuit before trial. The case would have been the first “bellwether” trial in a California state court consolidation of ASR...